3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Thoracic
8
Gastrointestinal
8
Head & Neck
2
Genitourinary
2
Dermatologic
2
Plasma cell
1
Lymphoid
1
CNS
1
Breast
1
Interventions
pembrolizumab
26
Specimen Handling
22
Biopsy
22
Magnetic Resonance Spectroscopy
20
Paclitaxel
12
Standard of Care
10
Carboplatin
10
Blood Specimen Collection
10
Bevacizumab
10
atezolizumab
9
Nivolumab
9
Cisplatin
8
Radiosurgery
7
Pemetrexed
7
Capecitabine
7
Surveys and Questionnaires
6
Gemcitabine
6
Cyclophosphamide
6
trastuzumab deruxtecan
5
durvalumab
5
X-Rays
5
Taxes
5
Radiotherapy
5
Irinotecan
5
Fluorouracil
5
olaparib
4
niraparib
4
cabozantinib
4
Oxaliplatin
4
Leucovorin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Erlotinib Hydrochloride
×
Tumor-Agnostic
×
90 days
×
Clear all
No trials found.